Hikma’s Injectables Business Expands As It Completes Custopharm Acquisition
Completion Of $425m Deal Comes Shortly After FTC Approved The Transaction
• By David Wallace
Hikma has now completed its deal to acquire Custopharm • Source: Cagkan Sayin / Alamy Stock Photo 
